Skip to main content
. 2004 Nov;138(2):312–316. doi: 10.1111/j.1365-2249.2004.02619.x

Table 2.

Clinical characteristics of patients: survival and sites of metastatic disease

Survival (months) since diagnosis of:

Patient Primary melanoma Cutaneous recurrence or unresectable regional lymph node metastasis Visceral or distant nodal metastasis
Slow progressors 1 79 71
2 52 24
3 156 81 47
4 156 120 94
5 82 58 47
6 98 74
7 107 107
8 126 67 63
Controls 9 41 41
10 228 48
11 34 4
12 22 5
13 16 12
14 17 17
15 46 18
16* 40
*

This elderly patient was receiving medical therapy for an unresected lentigo maligna melanoma of the face.